Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Articles

IgL Translocations for Risk Stratification in Multiple Myeloma

Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2019) 16 (5)

https://doi.org/10.1182/hem.V16.5.9790

Published: 2019

Articles

Repositioning the Repurposed Drug, a Structural Study of Thalidomide Analogs

Mahshid Rahmat, PhD, Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2019) 16 (3)

https://doi.org/10.1182/hem.V16.3.9556

Published: 2019

Articles

The Microbiome: A New Variable in Multiple Myeloma Disease Progression

Yujia Shen, PhD, Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2019) 16 (2)

https://doi.org/10.1182/hem.V16.2.9386

Published: 2019

Articles

In Search of Missed Tumors: Next-Generation Sequencing for Minimal Residual Disease Detection in Multiple Myeloma Comes of Age

Shuai Dong, PhD, Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2018) 16 (1)

https://doi.org/10.1182/hem.V16.1.9279

Published: 2018

Articles

Targeting a Myeloma Translocation for the First Time: The t(11;14) Journey

Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2018) 15 (4)

https://doi.org/10.1182/hem.V15.4.8715

Published: 2018

Articles

When Does Monoclonal Gammopathy Acquire Significance?

Chia-Jen Liu, MD, PhD, Mark Bustoros, MD, Romanos Sklavenitis Pistofidis, MD, Irene M. Ghobrial, MD

The Hematologist (2018) 15 (2)

https://doi.org/10.1182/hem.V15.2.8292

Published: 2018